Salicylanilide derivatives block Mycobacterium tuberculosis through inhibition of isocitrate lyase and methionine aminopeptidase
Language English Country Scotland Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
22765970
DOI
10.1016/j.tube.2012.06.001
PII: S1472-9792(12)00132-1
Knihovny.cz E-resources
- MeSH
- Antitubercular Agents metabolism pharmacology MeSH
- Isocitrate Lyase antagonists & inhibitors MeSH
- Humans MeSH
- Methionyl Aminopeptidases antagonists & inhibitors MeSH
- Microbial Sensitivity Tests MeSH
- Tuberculosis, Multidrug-Resistant drug therapy immunology microbiology MeSH
- Mycobacterium tuberculosis drug effects enzymology isolation & purification MeSH
- Salicylanilides metabolism pharmacology MeSH
- Socioeconomic Factors MeSH
- Dose-Response Relationship, Drug MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Czech Republic MeSH
- Names of Substances
- Antitubercular Agents MeSH
- Isocitrate Lyase MeSH
- Methionyl Aminopeptidases MeSH
- salicylanilide MeSH Browser
- Salicylanilides MeSH
The global burden of tuberculosis, its health and socio-economic impacts, the presence of drug-resistant forms and a potential threat of latent tuberculosis should serve as a strong impetus for the development of novel antituberculosis agents. We reported the in vitro activity of salicylanilide benzoates and pyrazine-2-carboxylates against Mycobacterium tuberculosis (minimum inhibitory concentrations as low as 0.5 μmol/L). Nineteen salicylanilide derivatives with mostly good antimycobacterial activity were evaluated for the inhibition of two essential mycobacterial enzymes, methionine aminopeptidase and isocitrate lyase, which are necessary for the maintenance of the latent tuberculosis infection. Salicylanilide derivatives act as moderate inhibitors of both mycobacterial and human methionine aminopeptidase and they also affect the function of mycobacterial isocitrate lyase. 4-Bromo-2-[4-(trifluoromethyl)phenylcarbamoyl]phenyl pyrazine-2-carboxylate was the most potent inhibitor of mycobacterial methionine aminopeptidase (41% inhibition at 10 μmol/L) and exhibited the highest selectivity. 5-Chloro-2-hydroxy-N-[4-(trifluoromethyl)phenyl]benzamide and 4-chloro-2-[4-(trifluoromethyl)phenylcarbamoyl]phenyl pyrazine-2-carboxylate caused 59% inhibition of isocitrate lyase at 100 μmol/L concentration and (S)-4-bromo-2-[4-(trifluoromethyl)phenylcarbamoyl]phenyl 2-acetamido-3-phenylpropanoate produced 22% inhibition at 10 μmol/L; this rate is approximately comparable to 3-nitropropionic acid. Inhibition of those enzymes contributes at least in part to the antimicrobial activity of the compounds.
References provided by Crossref.org
Salicylanilides and Their Anticancer Properties
Sulfadiazine Salicylaldehyde-Based Schiff Bases: Synthesis, Antimicrobial Activity and Cytotoxicity
Novel Cholinesterase Inhibitors Based on O-Aromatic N,N-Disubstituted Carbamates and Thiocarbamates
Salicylanilide diethyl phosphates as potential inhibitors of some mycobacterial enzymes
Antibacterial and herbicidal activity of ring-substituted 2-hydroxynaphthalene-1-carboxanilides
Antibacterial and herbicidal activity of ring-substituted 3-hydroxynaphthalene-2-carboxanilides
Antibacterial activity of salicylanilide 4-(trifluoromethyl)-benzoates